Peggy Peck
MedPage Today
Contact Peggy
Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.
| Recent: |
|
| Past: |
|
Past articles by Peggy:
No Longer Appearing in This Space
Peggy Peck, MedPage Today founding editor, stepping down → Read More
From Payers to Big Pharma: The Best of Milton Packer
As a Thanksgiving treat, MedPage Today presents Milton Packer's greatest hits -- as a blogger! → Read More
Price Resigns over Flightgate Scandal
With criticism from fellow Republicans growing, Tom Price steps down from HHS post → Read More
ESC: At Long Last, Inflammatory Hypothesis Confirmed in CVD by CANTOS
* Note that this large randomized trial demonstrated that the anti-IL-1 therapy canakinumab reduces the rate of myocardial infarction among those with prior MI and an elevated CRP. * Be aware that deaths from infection were significantly more common in the canakinumab arm. BARCELONA -- Long-awaited evidence that targeting an inflammatory pathway can reduce heart attacks and stroke independent of… → Read More
Barcelona Attack Doesn't Derail ESC Plans
Cardiologists hang tough: 'If we change behavior, the terrorists have won' → Read More
McCain and Kennedy: Have We Seen This Before?
Deja vu, that's what it is. When reports about a blood clot being removed "above the left eye" of Sen. John McCain (R-Ariz.) came in last Saturday, there was something unmistakably familiar about this news. Especially the line about awaiting results of a pathology report. Pathology for a blood clot? A 5-cm blood clot above the eye? Something did not ring true, but at the same time triggered… → Read More
Fake News Stops Here
Fake news is a problem, but it is also not what is offered by MedPage Today → Read More
Doctors Shot in Bronx Hospital
At least three doctors injured in what appears to be attack by lone gunman → Read More
AMA, I Hardly Knew Ye
Group's annual meeting folds its tent, but that tent has really changed → Read More
Drug Prices, VA Care, Travel Ban on Agenda at AMA
AMA to debate adding retail price to those consumer drug ads → Read More
FOURIER Opens ACC With a Bang
Big LDL reduction, prevents MI, but with big price tag → Read More
'Nobody Knew': Is That a Fact?
President Donald J. Trump has said many surprising and sometimes shocking things since he became the 45th President of the United States, but on Monday he made what is arguably his most shocking statement: "Nobody knew that healthcare could be so complicated." Really? I think he is wrong about that. So who knew? One could start, and probably should start, with the hundreds of thousands of… → Read More
Trump Denies Naming Vax Skeptic to Safety Panel
Robert F. Kennedy Jr., a well-known critic of pediatric immunization programs, says President-elect Donald Trump asked him to head a "new commission on vaccine safety and scientific integrity," according to The Washington Post. But hours after Kennedy's statement, the Trump team said a commission on autism was in the works, but no decision has been made about who will head it. It is unclear if… → Read More
AHA: Real World TAVR Is All About Patient Selection
NEW ORLEANS -- In a real world registry trial comparing transcatheter aortic valve replacement (TAVR) to surgical aortic valve replacement (SAVR) in intermediate risk patients, the mortality at one year was nearly twice as high in the TAVR group, but those patients were also older and more frail than the surgery patients. One-year mortality was 16.9% with TAVR versus 8.9 for SAVR (P<0.001),… → Read More
AHA: Questions Raised About Journal Paper
Clash of the Titans? → Read More
AHA: Study Finds Celebrex Safe for Heart
NEW ORLEANS -- After 10 years during which 24,000 osteoarthritis (OA) and rheumatoid arthritis (RA) patients were randomized, the verdict on cardiovascular safety of NSAIDs is in and it's not all that surprising: celecoxib (Celebrex) is no more likely to cause heart attacks or stroke than naproxen or ibuprofen. In fact the surprise in the long-awaited PRECISION study was not about the… → Read More
AAFP Exec Declares Healthcare 'Fundamental Human Right'
ORLANDO -- The chief executive at the American Academy of Family Physicians scolded FPs for being too eager to refer patients to subspecialists and for their "sorry performance" in providing after-hours and weekend access for patients. But Douglas Henley, MD, AAFP executive vice president and CEO, also exhorted the assembled members of the Congress of Delegates to "firmly defend healthcare as a… → Read More
AMA: Broad Coalition Backs End to Ban on Gun Violence Research
CHICAGO -- The American Academy of Family Physicians joined with the American Medical Association's (AMA) Minority Affairs Section and its Young Physicians Section, along with several other groups, to demand that Congress lift its ban on funding gun violence research by the Centers for Disease Control and Prevention. The coalition, which formed quickly in the hours following the Sunday morning… → Read More
Opioids to Transgender: AMA Agenda Promises Heated Debate
CHICAGO -- The American Medical Association will open its annual House of Delegates meeting here Saturday and its agenda highlights many of the same issues that have been grabbing national headlines -- transgender rights, Medicare, the Zika virus, and safe treatment of pain. Those issues come before the House in a series of reports and resolutions, all of which must be discussed, debated, and… → Read More
Statins in the Spotlight; Leadless Pacemaker; Is TAVR the Future?
Cardiovascular Daily wraps up the top cardiology news of the week → Read More